• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮功能障碍与失调的淋巴细胞反应和细胞因子网络共同导致了严重的 COVID-19。

Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.

机构信息

Institute of Transplant Immunology, MHH, D, Hanover, Germany.

Department of Pneumology, MHH, D, Hanover, Germany.

出版信息

Signal Transduct Target Ther. 2021 Dec 10;6(1):418. doi: 10.1038/s41392-021-00819-6.

DOI:10.1038/s41392-021-00819-6
PMID:34893580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8661333/
Abstract

The systemic processes involved in the manifestation of life-threatening COVID-19 and in disease recovery are still incompletely understood, despite investigations focusing on the dysregulation of immune responses after SARS-CoV-2 infection. To define hallmarks of severe COVID-19 in acute disease (n = 58) and in disease recovery in convalescent patients (n = 28) from Hannover Medical School, we used flow cytometry and proteomics data with unsupervised clustering analyses. In our observational study, we combined analyses of immune cells and cytokine/chemokine networks with endothelial activation and injury. ICU patients displayed an altered immune signature with prolonged lymphopenia but the expansion of granulocytes and plasmablasts along with activated and terminally differentiated T and NK cells and high levels of SARS-CoV-2-specific antibodies. The core signature of seven plasma proteins revealed a highly inflammatory microenvironment in addition to endothelial injury in severe COVID-19. Changes within this signature were associated with either disease progression or recovery. In summary, our data suggest that besides a strong inflammatory response, severe COVID-19 is driven by endothelial activation and barrier disruption, whereby recovery depends on the regeneration of the endothelial integrity.

摘要

尽管针对 SARS-CoV-2 感染后免疫反应失调的研究已经开展,但危及生命的 COVID-19 表现和疾病康复过程中的系统机制仍未被完全理解。为了定义汉诺威医学院急性疾病(n=58)和恢复期患者(n=28)中严重 COVID-19 的特征,我们使用流式细胞术和蛋白质组学数据进行无监督聚类分析。在我们的观察性研究中,我们将免疫细胞和细胞因子/趋化因子网络分析与内皮细胞激活和损伤相结合。ICU 患者表现出改变的免疫特征,表现为持续的淋巴细胞减少,但粒细胞和浆母细胞的扩增,以及激活和终末分化的 T 和 NK 细胞以及高水平的 SARS-CoV-2 特异性抗体。七种血浆蛋白的核心特征除了严重 COVID-19 中的内皮损伤外,还揭示了一个高度炎症的微环境。该特征内的变化与疾病进展或恢复有关。总之,我们的数据表明,除了强烈的炎症反应外,严重的 COVID-19 还受到内皮激活和屏障破坏的驱动,而恢复则取决于内皮完整性的再生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/d713e74745e3/41392_2021_819_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/a5cc40206726/41392_2021_819_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/fc06ecd1d458/41392_2021_819_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/64a3c7ff722b/41392_2021_819_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/e1f94ac6c4ac/41392_2021_819_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/803de9af81e2/41392_2021_819_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/0175d0a4ebf5/41392_2021_819_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/d713e74745e3/41392_2021_819_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/a5cc40206726/41392_2021_819_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/fc06ecd1d458/41392_2021_819_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/64a3c7ff722b/41392_2021_819_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/e1f94ac6c4ac/41392_2021_819_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/803de9af81e2/41392_2021_819_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/0175d0a4ebf5/41392_2021_819_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e176/8664841/d713e74745e3/41392_2021_819_Fig7_HTML.jpg

相似文献

1
Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.内皮功能障碍与失调的淋巴细胞反应和细胞因子网络共同导致了严重的 COVID-19。
Signal Transduct Target Ther. 2021 Dec 10;6(1):418. doi: 10.1038/s41392-021-00819-6.
2
Laboratory biomarkers and prognosis in Covid-19, where do we stand?新冠病毒病中的实验室生物标志物与预后,我们目前的进展如何?
Rev Med Virol. 2021 Nov;31(6):e2296. doi: 10.1002/rmv.2296. Epub 2021 Sep 13.
3
Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients.严重/危重症 COVID-19 患者急性和康复期的免疫和炎症特征。
Int Immunopharmacol. 2021 Aug;97:107685. doi: 10.1016/j.intimp.2021.107685. Epub 2021 Apr 17.
4
Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.慢性阻塞性肺疾病患者的血浆炎症介质水平升高,这些炎症介质在重症 COVID-19 中被报道上调。
Front Immunol. 2021 Jul 15;12:678661. doi: 10.3389/fimmu.2021.678661. eCollection 2021.
5
Cytokine storm in severe COVID-19 pneumonia.重症 COVID-19 肺炎中的细胞因子风暴。
J Med Virol. 2021 Sep;93(9):5474-5480. doi: 10.1002/jmv.27068. Epub 2021 May 15.
6
Storm of soluble immune checkpoints associated with disease severity of COVID-19.与新型冠状病毒肺炎疾病严重程度相关的可溶性免疫检查点风暴
Signal Transduct Target Ther. 2020 Sep 7;5(1):192. doi: 10.1038/s41392-020-00308-2.
7
Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?新冠康复者血浆疗法:一种久经考验的古老策略?
Signal Transduct Target Ther. 2020 Sep 15;5(1):203. doi: 10.1038/s41392-020-00310-8.
8
Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.促炎细胞因子与 COVID-19 患者病毒 RNA 持续脱落有关。
Clin Immunol. 2020 Dec;221:108611. doi: 10.1016/j.clim.2020.108611. Epub 2020 Oct 14.
9
Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses.COVID-19 患者严重程度的相关因素:细胞因子/趋化因子浓度、病毒载量和抗体反应。
Am J Trop Med Hyg. 2020 Dec;103(6):2412-2418. doi: 10.4269/ajtmh.20-1110. Epub 2020 Oct 27.
10
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.2019冠状病毒病危重症患者中与脓毒症相关的严重白细胞介素-6风暴
Cell Mol Immunol. 2020 Oct;17(10):1092-1094. doi: 10.1038/s41423-020-00522-6. Epub 2020 Sep 11.

引用本文的文献

1
Endothelial activation and stress index for prediction of mortality in asthma.用于预测哮喘死亡率的内皮激活和应激指数
Front Med (Lausanne). 2025 Jul 9;12:1622944. doi: 10.3389/fmed.2025.1622944. eCollection 2025.
2
Cord blood cytokines/chemokines linked to delays in toddlers exposed to SARS-CoV-2 prenatally.与产前暴露于新冠病毒的幼儿发育迟缓相关的脐带血细胞因子/趋化因子。
Pediatr Res. 2025 Jun 11. doi: 10.1038/s41390-025-04192-w.
3
Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies.

本文引用的文献

1
The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.锌指转录因子 KLF2 可预防 COVID-19 相关的内皮功能障碍。
Signal Transduct Target Ther. 2021 Jul 12;6(1):266. doi: 10.1038/s41392-021-00690-5.
2
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.单核细胞驱动的非典型细胞因子风暴和异常中性粒细胞激活作为 COVID-19 疾病严重程度的关键介质。
Nat Commun. 2021 Jul 5;12(1):4117. doi: 10.1038/s41467-021-24360-w.
3
Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.
急性呼吸窘迫综合征的进展:聚焦于异质性、病理生理学和治疗策略。
Signal Transduct Target Ther. 2025 Mar 7;10(1):75. doi: 10.1038/s41392-025-02127-9.
4
Exploratory analyses of leukocyte responses in hospitalized patients treated with ozanimod following a severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染后接受奥扎莫德治疗的住院患者白细胞反应的探索性分析。
Immunol Cell Biol. 2025 May;103(5):433-443. doi: 10.1111/imcb.70006. Epub 2025 Mar 2.
5
Unveiling the immunomodulatory dance: endothelial cells' function and their role in non-small cell lung cancer.揭示免疫调节之舞:内皮细胞的功能及其在非小细胞肺癌中的作用。
Mol Cancer. 2025 Jan 16;24(1):21. doi: 10.1186/s12943-024-02221-6.
6
Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms.靶向血管紧张素 II 受体 1(AGTR1)的失调自身抗体与 COVID-19 症状的积累有关。
NPJ Syst Biol Appl. 2025 Jan 13;11(1):7. doi: 10.1038/s41540-025-00488-z.
7
GPR68 Mediates Lung Endothelial Dysfunction Caused by Bacterial Inflammation and Tissue Acidification.GPR68介导细菌炎症和组织酸化引起的肺内皮功能障碍。
Cells. 2024 Dec 22;13(24):2125. doi: 10.3390/cells13242125.
8
Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection.人疱疹病毒再激活及其在新型冠状病毒肺炎感染后急性后遗症发病机制中的潜在作用。
Geroscience. 2025 Feb;47(1):167-187. doi: 10.1007/s11357-024-01323-9. Epub 2024 Aug 29.
9
Familial Hypercholesterolemia Patients with COVID-19-Effective Cholesterol-Lowering Therapy is Urgent both during and after Infection.家族性高胆固醇血症合并新型冠状病毒肺炎患者——感染期间及感染后均急需有效的降胆固醇治疗
Rev Cardiovasc Med. 2022 Dec 19;23(12):410. doi: 10.31083/j.rcm2312410. eCollection 2022 Dec.
10
The Impact of Pentraxin 3 Serum Levels and Angiotensin-Converting Enzyme Polymorphism on Pulmonary Infiltrates and Mortality in COVID-19 Patients.五聚体蛋白3血清水平和血管紧张素转换酶多态性对COVID-19患者肺部浸润和死亡率的影响
Biomedicines. 2024 Jul 20;12(7):1618. doi: 10.3390/biomedicines12071618.
儿童新冠病毒相关多系统炎症综合征、川崎病和巨噬细胞活化综合征中的炎症生物标志物:一项队列研究
Lancet Rheumatol. 2021 Aug;3(8):e574-e584. doi: 10.1016/S2665-9913(21)00139-9. Epub 2021 Jun 8.
4
Post-acute COVID-19 syndrome.新冠病毒感染后长期综合征。
Nat Med. 2021 Apr;27(4):601-615. doi: 10.1038/s41591-021-01283-z. Epub 2021 Mar 22.
5
COVID-19 and the human innate immune system.新型冠状病毒肺炎与人类固有免疫系统。
Cell. 2021 Apr 1;184(7):1671-1692. doi: 10.1016/j.cell.2021.02.029. Epub 2021 Feb 16.
6
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.在 COVID-19 患者中,功能性 SARS-CoV-2 特异性 T 细胞的早期诱导与快速病毒清除和轻症疾病相关。
Cell Rep. 2021 Feb 9;34(6):108728. doi: 10.1016/j.celrep.2021.108728. Epub 2021 Jan 21.
7
Adaptive immunity to SARS-CoV-2 and COVID-19.对 SARS-CoV-2 和 COVID-19 的适应性免疫。
Cell. 2021 Feb 18;184(4):861-880. doi: 10.1016/j.cell.2021.01.007. Epub 2021 Jan 12.
8
Evolution of antibody immunity to SARS-CoV-2.SARS-CoV-2 抗体免疫的演变。
Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.
9
PD-1-Expressing SARS-CoV-2-Specific CD8 T Cells Are Not Exhausted, but Functional in Patients with COVID-19.PD-1 表达的 SARS-CoV-2 特异性 CD8 T 细胞并未衰竭,而是在 COVID-19 患者中具有功能。
Immunity. 2021 Jan 12;54(1):44-52.e3. doi: 10.1016/j.immuni.2020.12.002. Epub 2020 Dec 14.
10
Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.通过I/III型干扰素的时间模式及流感对比揭示的新冠病毒感染中失调的抗病毒免疫
Nat Immunol. 2021 Jan;22(1):32-40. doi: 10.1038/s41590-020-00840-x. Epub 2020 Dec 4.